|
Volumn 65, Issue 21, 1999, Pages 2259-2268
|
Nitric oxide synthesis inhibition suppresses implantation and decreases cGMP concentration and protein peroxidation
a a a b a c |
Author keywords
cGMP; Embryonic development; Implantation; Nitric oxide; Protein peroxidation
|
Indexed keywords
ARGININE;
CELL PROTEIN;
CYCLIC GMP;
ESTROGEN;
GUANYLATE CYCLASE;
NITRIC OXIDE;
PROSTAGLANDIN E2;
PROSTAGLANDIN F2 ALPHA;
SUPEROXIDE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONCENTRATION LOSS;
CONTROLLED STUDY;
DRUG HALF LIFE;
DRUG MECHANISM;
EMBRYO;
EMBRYO DEVELOPMENT;
ENDOMETRIUM;
EXPERIMENTAL MODEL;
FEMALE;
NIDATION;
NONHUMAN;
PEROXIDATION;
PREECLAMPSIA;
RAT;
VASODILATATION;
ANIMALS;
CYCLIC AMP;
CYCLIC GMP;
EMBRYO IMPLANTATION;
EMBRYONIC AND FETAL DEVELOPMENT;
ENDOMETRIUM;
ENZYME INHIBITORS;
FEMALE;
INDICATORS AND REAGENTS;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITROARGININE;
OXIDATION-REDUCTION;
PEROXIDES;
PHENYLHYDRAZINES;
PREGNANCY;
PREGNANCY, ANIMAL;
PROTEINS;
RATS;
RATS, SPRAGUE-DAWLEY;
ANIMALIA;
|
EID: 0033569468
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(99)00491-9 Document Type: Article |
Times cited : (29)
|
References (46)
|